Funding announcements all sound alike — unless you give journalists a reason to care. For VitaLoop's $85M Series C, Pressmark Communications led with patient outcomes instead of the round size: 120,000 personalised treatment plans delivered, and readmission rates down 23% across partner clinics.
We coordinated the announcement across three audiences at once: an exclusive for a national tech title, embargoed briefings for healthcare trade press, and a founder Q&A for the investor's own channels — all landing on the same morning.
“Pressmark Communications ran the announcement like a campaign, not a press release. Every audience heard the news in their own language.” — Dr. Alan Reyes, CEO, VitaLoop
The result was nineteen articles in two days, including pickups that quoted VitaLoop's clinical data rather than just the funding figure — exactly the credibility a healthcare company needs before scaling.
The outcome
Nineteen pieces of coverage, a 5x spike in clinician partnership enquiries, and a messaging framework VitaLoop still uses for every milestone.
